Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Main Authors: Hoeflich, Andreas, Fitzner, Brit, Walz, Christina, Hecker, Michael, Tuchscherer, Armin, Bastian, Manuela, Brenmoehl, Julia, Schröder, Ina, Willenberg, Holger S., Reincke, Martin, Zettl, Uwe Klaus
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Endocrinology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481359/
https://ncbi.nlm.nih.gov/pubmed/32982971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00574
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares